OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
March 03, 2023
Lipids aren’t the only important ingredients influencing stability and in vivo performance.
March 01, 2023
Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.
February 03, 2023
Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.
February 02, 2023
In vivo CAR-T gene therapies could resolve challenges faced by autologous and allogeneic treatments.
January 03, 2023
Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.
December 03, 2022
Unique solutions are required to protect inherently unstable messenger RNA.